Logo image of SRAD

SPORTRADAR GROUP AG-A (SRAD) Stock Fundamental Analysis

NASDAQ:SRAD - Nasdaq - CH1134239669 - Common Stock - Currency: USD

21.26  -1.03 (-4.62%)

After market: 21.2 -0.06 (-0.28%)

Fundamental Rating

6

Overall SRAD gets a fundamental rating of 6 out of 10. We evaluated SRAD against 135 industry peers in the Hotels, Restaurants & Leisure industry. SRAD has only an average score on both its financial health and profitability. SRAD is valued quite expensive, but it does show an excellent growth. These ratings could make SRAD a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SRAD had positive earnings in the past year.
SRAD had a positive operating cash flow in the past year.
In the past 5 years SRAD has always been profitable.
Each year in the past 5 years SRAD had a positive operating cash flow.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of SRAD (2.58%) is comparable to the rest of the industry.
SRAD's Return On Equity of 6.43% is in line compared to the rest of the industry. SRAD outperforms 59.54% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.84%, SRAD is in line with its industry, outperforming 41.22% of the companies in the same industry.
SRAD had an Average Return On Invested Capital over the past 3 years of 2.22%. This is significantly below the industry average of 10.79%.
The 3 year average ROIC (2.22%) for SRAD is below the current ROIC(3.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.58%
ROE 6.43%
ROIC 3.84%
ROA(3y)1.01%
ROA(5y)1.25%
ROE(3y)2.38%
ROE(5y)4.74%
ROIC(3y)2.22%
ROIC(5y)3.49%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2 4 6 8

1.3 Margins

The Profit Margin of SRAD (5.57%) is better than 60.31% of its industry peers.
SRAD's Profit Margin has improved in the last couple of years.
SRAD has a Operating Margin (10.51%) which is in line with its industry peers.
In the last couple of years the Operating Margin of SRAD has declined.
Looking at the Gross Margin, with a value of 73.72%, SRAD belongs to the top of the industry, outperforming 90.08% of the companies in the same industry.
In the last couple of years the Gross Margin of SRAD has remained more or less at the same level.
Industry RankSector Rank
OM 10.51%
PM (TTM) 5.57%
GM 73.72%
OM growth 3Y-11.88%
OM growth 5YN/A
PM growth 3Y1.7%
PM growth 5YN/A
GM growth 3Y-0.6%
GM growth 5YN/A
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 20 40 60 80

6

2. Health

2.1 Basic Checks

SRAD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SRAD has been increased compared to 1 year ago.
Compared to 1 year ago, SRAD has a worse debt to assets ratio.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 3.66 indicates that SRAD is not in any danger for bankruptcy at the moment.
SRAD has a better Altman-Z score (3.66) than 79.39% of its industry peers.
SRAD has a debt to FCF ratio of 0.36. This is a very positive value and a sign of high solvency as it would only need 0.36 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.36, SRAD belongs to the best of the industry, outperforming 93.13% of the companies in the same industry.
SRAD has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
SRAD has a better Debt to Equity ratio (0.04) than 86.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.36
Altman-Z 3.66
ROIC/WACC0.73
WACC5.26%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.53 indicates that SRAD should not have too much problems paying its short term obligations.
SRAD's Current ratio of 1.53 is fine compared to the rest of the industry. SRAD outperforms 73.28% of its industry peers.
A Quick Ratio of 1.53 indicates that SRAD should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.53, SRAD is doing good in the industry, outperforming 75.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M 800M

9

3. Growth

3.1 Past

SRAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 575.00%, which is quite impressive.
Measured over the past years, SRAD shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.72% on average per year.
The Revenue has grown by 26.56% in the past year. This is a very strong growth!
The Revenue has been growing by 29.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)575%
EPS 3Y30.72%
EPS 5YN/A
EPS Q2Q%120%
Revenue 1Y (TTM)26.56%
Revenue growth 3Y29.42%
Revenue growth 5YN/A
Sales Q2Q%26.93%

3.2 Future

SRAD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.28% yearly.
Based on estimates for the next years, SRAD will show a quite strong growth in Revenue. The Revenue will grow by 14.97% on average per year.
EPS Next Y0.88%
EPS Next 2Y31.5%
EPS Next 3Y40.72%
EPS Next 5Y41.28%
Revenue Next Year24.88%
Revenue Next 2Y19.5%
Revenue Next 3Y16.9%
Revenue Next 5Y14.97%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 106.30, the valuation of SRAD can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SRAD indicates a slightly more expensive valuation: SRAD is more expensive than 64.12% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.63, SRAD is valued quite expensively.
SRAD is valuated quite expensively with a Price/Forward Earnings ratio of 78.49.
SRAD's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SRAD is more expensive than 64.89% of the companies in the same industry.
SRAD's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 106.3
Fwd PE 78.49
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRAD is on the same level as its industry peers.
SRAD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 46.6
EV/EBITDA 15.38
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRAD does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SRAD may justify a higher PE ratio.
A more expensive valuation may be justified as SRAD's earnings are expected to grow with 40.72% in the coming years.
PEG (NY)120.14
PEG (5Y)N/A
EPS Next 2Y31.5%
EPS Next 3Y40.72%

0

5. Dividend

5.1 Amount

No dividends for SRAD!.
Industry RankSector Rank
Dividend Yield N/A

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (2/21/2025, 8:00:00 PM)

After market: 21.2 -0.06 (-0.28%)

21.26

-1.03 (-4.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners85.37%
Inst Owner Change3.35%
Ins Owners2.22%
Ins Owner ChangeN/A
Market Cap6.34B
Analysts80
Price Target20.27 (-4.66%)
Short Float %2.81%
Short Ratio7.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)89.2%
Min EPS beat(2)-100%
Max EPS beat(2)278.4%
EPS beat(4)2
Avg EPS beat(4)42.11%
Min EPS beat(4)-100%
Max EPS beat(4)278.4%
EPS beat(8)2
Avg EPS beat(8)-48.13%
EPS beat(12)6
Avg EPS beat(12)3.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.13%
Min Revenue beat(2)3.38%
Max Revenue beat(2)4.89%
Revenue beat(4)3
Avg Revenue beat(4)3.3%
Min Revenue beat(4)-0.6%
Max Revenue beat(4)5.54%
Revenue beat(8)4
Avg Revenue beat(8)0.27%
Revenue beat(12)8
Avg Revenue beat(12)1.05%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.26%
PT rev (3m)21.15%
EPS NQ rev (1m)-9.08%
EPS NQ rev (3m)-21.25%
EPS NY rev (1m)3.16%
EPS NY rev (3m)96.5%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1%
Valuation
Industry RankSector Rank
PE 106.3
Fwd PE 78.49
P/S 5.77
P/FCF 46.6
P/OCF 18.79
P/B 6.66
P/tB N/A
EV/EBITDA 15.38
EPS(TTM)0.2
EY0.94%
EPS(NY)0.27
Fwd EY1.27%
FCF(TTM)0.46
FCFY2.15%
OCF(TTM)1.13
OCFY5.32%
SpS3.68
BVpS3.19
TBVpS-2.48
PEG (NY)120.14
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.58%
ROE 6.43%
ROCE 5.8%
ROIC 3.84%
ROICexc 4.76%
ROICexgc N/A
OM 10.51%
PM (TTM) 5.57%
GM 73.72%
FCFM 12.38%
ROA(3y)1.01%
ROA(5y)1.25%
ROE(3y)2.38%
ROE(5y)4.74%
ROIC(3y)2.22%
ROIC(5y)3.49%
ROICexc(3y)3.29%
ROICexc(5y)5.26%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.36%
ROCE(5y)5.28%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-30.22%
ROICexc growth 5YN/A
OM growth 3Y-11.88%
OM growth 5YN/A
PM growth 3Y1.7%
PM growth 5YN/A
GM growth 3Y-0.6%
GM growth 5YN/A
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.36
Debt/EBITDA 0.09
Cap/Depr 68.28%
Cap/Sales 18.33%
Interest Coverage 1.52
Cash Conversion 82.21%
Profit Quality 222.12%
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z 3.66
F-Score5
WACC5.26%
ROIC/WACC0.73
Cap/Depr(3y)93.93%
Cap/Depr(5y)83.46%
Cap/Sales(3y)22.8%
Cap/Sales(5y)23.49%
Profit Quality(3y)76.66%
Profit Quality(5y)202.93%
High Growth Momentum
Growth
EPS 1Y (TTM)575%
EPS 3Y30.72%
EPS 5YN/A
EPS Q2Q%120%
EPS Next Y0.88%
EPS Next 2Y31.5%
EPS Next 3Y40.72%
EPS Next 5Y41.28%
Revenue 1Y (TTM)26.56%
Revenue growth 3Y29.42%
Revenue growth 5YN/A
Sales Q2Q%26.93%
Revenue Next Year24.88%
Revenue Next 2Y19.5%
Revenue Next 3Y16.9%
Revenue Next 5Y14.97%
EBIT growth 1Y78.12%
EBIT growth 3Y14.04%
EBIT growth 5YN/A
EBIT Next Year192.33%
EBIT Next 3Y64.52%
EBIT Next 5Y45.13%
FCF growth 1Y974.26%
FCF growth 3Y0.62%
FCF growth 5YN/A
OCF growth 1Y108.72%
OCF growth 3Y19.57%
OCF growth 5YN/A